PL1713446T3 - Nielamelarne trójskładnikowe kompozycje lipidów - Google Patents

Nielamelarne trójskładnikowe kompozycje lipidów

Info

Publication number
PL1713446T3
PL1713446T3 PL05701965T PL05701965T PL1713446T3 PL 1713446 T3 PL1713446 T3 PL 1713446T3 PL 05701965 T PL05701965 T PL 05701965T PL 05701965 T PL05701965 T PL 05701965T PL 1713446 T3 PL1713446 T3 PL 1713446T3
Authority
PL
Poland
Prior art keywords
compositions
amphiphile
lipid compositions
component
lamellar lipid
Prior art date
Application number
PL05701965T
Other languages
English (en)
Inventor
Markus Johnsson
Fredrik Tiberg
Original Assignee
Camurus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0401515.2A external-priority patent/GB0401515D0/en
Priority claimed from GB0407936A external-priority patent/GB0407936D0/en
Application filed by Camurus Ab filed Critical Camurus Ab
Publication of PL1713446T3 publication Critical patent/PL1713446T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Edible Oils And Fats (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL05701965T 2004-01-23 2005-01-21 Nielamelarne trójskładnikowe kompozycje lipidów PL1713446T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0401515.2A GB0401515D0 (en) 2004-01-23 2004-01-23 Compositions
GB0407936A GB0407936D0 (en) 2004-04-07 2004-04-07 Compositions
PCT/GB2005/000202 WO2005070394A2 (en) 2004-01-23 2005-01-21 Ternary non-lamellar lipid compositions
EP05701965A EP1713446B1 (en) 2004-01-23 2005-01-21 Ternary non-lamellar lipid compositions

Publications (1)

Publication Number Publication Date
PL1713446T3 true PL1713446T3 (pl) 2011-05-31

Family

ID=34809883

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05701965T PL1713446T3 (pl) 2004-01-23 2005-01-21 Nielamelarne trójskładnikowe kompozycje lipidów

Country Status (8)

Country Link
US (1) US8182834B2 (pl)
EP (1) EP1713446B1 (pl)
JP (1) JP4966018B2 (pl)
AT (1) ATE489942T1 (pl)
CA (1) CA2554052C (pl)
DE (1) DE602005025083D1 (pl)
PL (1) PL1713446T3 (pl)
WO (1) WO2005070394A2 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005324794C1 (en) * 2003-11-07 2010-12-02 Camurus Ab Somatostatin analogue formulations
GB0401513D0 (en) * 2004-01-23 2004-02-25 Camurus Ab Compositions
EP1848403B8 (en) * 2005-01-14 2010-05-19 Camurus Ab Topical bioadhesive formulations
US8871712B2 (en) * 2005-01-14 2014-10-28 Camurus Ab Somatostatin analogue formulations
SI1845942T1 (sl) 2005-01-14 2014-06-30 Camurus Ab Gnrh analogne formulacije
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
KR101245022B1 (ko) 2005-01-21 2013-03-19 카무러스 에이비 약제학적 지질 조성물
DK1888031T3 (da) 2005-06-06 2013-02-18 Camurus Ab GLP-1-analogformuleringer
JP5368793B2 (ja) 2005-07-18 2013-12-18 ユニバーシティ オブ マサチューセッツ ロウエル ナノエマルジョンを製造および使用するための組成物および方法
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
AU2007353340A1 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
CA2688415C (en) 2007-05-31 2015-11-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
EP2020221B1 (de) * 2007-06-19 2012-02-29 Neubourg Skin Care GmbH & Co. KG DMS (Derma Membrane Structure) in Schaum-Cremes
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
PT104158B (pt) * 2008-08-18 2011-02-24 Univ Do Minho Aplicação da monooleína como novo lípido adjuvante em lipofecção
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
BR112014013693B1 (pt) 2011-12-05 2023-01-31 Camurus Ab Pré-formulação, e, uso de uma pré-formulação
ES2834318T3 (es) 2012-05-25 2021-06-17 Camurus Ab Formulaciones de agonistas de receptores de la somatostatina
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達
WO2020190746A1 (en) 2019-03-15 2020-09-24 Saudi Arabian Oil Company Bulk synthesis of janus nanomaterials
US12228512B2 (en) 2019-07-16 2025-02-18 Saudi Arabian Oil Company Multipurpose microfluidics devices for rapid on-site optical chemical analysis
US11422285B2 (en) 2020-06-17 2022-08-23 Saudi Arabian Oil Company Nanofluidic chips as micromodels for carbonate reservoirs
US11827850B2 (en) 2020-07-24 2023-11-28 Saudi Arabian Oil Company Enhanced oil recovery with janus nanoparticles
US11773715B2 (en) 2020-09-03 2023-10-03 Saudi Arabian Oil Company Injecting multiple tracer tag fluids into a wellbore
US11660595B2 (en) 2021-01-04 2023-05-30 Saudi Arabian Oil Company Microfluidic chip with multiple porosity regions for reservoir modeling
US11534759B2 (en) 2021-01-22 2022-12-27 Saudi Arabian Oil Company Microfluidic chip with mixed porosities for reservoir modeling
US12253467B2 (en) 2021-12-13 2025-03-18 Saudi Arabian Oil Company Determining partition coefficients of tracer analytes
US12000278B2 (en) 2021-12-16 2024-06-04 Saudi Arabian Oil Company Determining oil and water production rates in multiple production zones from a single production well
US12352146B2 (en) 2023-09-11 2025-07-08 Saudi Arabian Oil Company Method for well stimulation using nanobubbles

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0643620B1 (en) 1991-10-04 1999-07-21 Gs Development Ab Particles, method of preparing said particles and uses thereof
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US5885613A (en) * 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
AU747252B2 (en) * 1997-09-09 2002-05-09 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
DE69922189T2 (de) * 1998-04-27 2005-11-10 Opperbas Holding B.V. Pharmazeutische zusammensetzungen enthaltend faktor viii und neutrale liposomen
US6537575B1 (en) * 1999-07-30 2003-03-25 The University Of Chicago Synthetic biological membrane with self organizing properties
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US7008646B2 (en) 2001-02-20 2006-03-07 Patrick Thomas Spicer Cubic liquid crystalline compositions and methods for their preparation
US6936187B2 (en) 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6656385B2 (en) 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
JP2007501213A (ja) * 2003-08-04 2007-01-25 カムルス エービー 両親媒性粒子に活性因子を装填する方法
GB0322033D0 (en) * 2003-09-19 2003-10-22 Camurus Ab Composition

Also Published As

Publication number Publication date
WO2005070394A3 (en) 2006-01-26
CA2554052C (en) 2013-10-22
DE602005025083D1 (pl) 2011-01-13
ATE489942T1 (de) 2010-12-15
CA2554052A1 (en) 2005-08-04
US20080206317A1 (en) 2008-08-28
US8182834B2 (en) 2012-05-22
JP4966018B2 (ja) 2012-07-04
EP1713446A2 (en) 2006-10-25
WO2005070394A2 (en) 2005-08-04
JP2007518784A (ja) 2007-07-12
EP1713446B1 (en) 2010-12-01

Similar Documents

Publication Publication Date Title
PL1713446T3 (pl) Nielamelarne trójskładnikowe kompozycje lipidów
WO2006032762A3 (fr) Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose
WO2006013369A3 (en) Compositions forming non-lamellar dispersions
MEP36508A (en) Triazolopyrazine derivatives useful as anti-cancer agents
WO2007090822A3 (de) Pharmazeutische formulierung für aerosole mit zwei oder mehr wirkstoffen und mindestens einer oberflächenaktiven substanz
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
SG161261A1 (en) Lactam compounds and their use as pharmaceuticals
DK1663216T3 (da) Tacrolimus-holdige sammensætninger med modificeret frigivelse
WO2006113631A3 (en) Bioenhanced compositions
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
NO20000466D0 (no) Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering
PL2046292T3 (pl) Preparaty eterów benzymidazolilo-pirydylowych
ATE522204T1 (de) Beschichtete pellets
WO2007022023A3 (en) Film forming spreading agents
BR0316724A (pt) Compostos, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
DE602005025082D1 (de) Nicht-lamellare zubereitungen von dioleoyl-phosphatidyl ethanolamin und polysorbat80
CA2388325A1 (en) Ciclesonide-containing aqueous pharmaceutical composition
WO2006041538A3 (en) A mixture for transdermal delivery of low and high molecular weight compounds
MXPA05011607A (es) Formulacion para producir un medicamento antimicrobinao potente contra organismos normalmente considerados resistentes al medicamento.
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
ITTO20040682A1 (it) Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare
UA93540C2 (ru) Фармацевтическая композиция для аэрозольного распыления c двумя действующими веществами и, по меньшей mepe, одним поверхностно-активным веществом
UA90700C2 (ru) Оральная композиция немедленного выделения на основе слабоводорастворимого действующего вещества
MA30496B1 (fr) Derives de 2-alcoxy -3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation